GHK-Cu LPT® is here. A compounded 2 mg chewable, bisected copper peptide tablet in a liposomal oral format.

Native iPhone Duo apps, built with Expo. Ship yours before your AppleCare appointment!

Yes Twitter biohacker, I know you get 12 vials for $50 bucks But no one wants to inject grandma with random BPC People want quality

A milestone worth celebrating. Six peptides are now in Category 1, a major win for patients, clinicians, and pharmacists. Proud to see years of advocacy for safe, regulated access move peptide medicine forward.

Want to utilize @strivepharmacy as your source of compounded peptides? I suggest getting signed up as a authorized prescriber NOW before the wave hits strivepharmacy.com/become-a-… We’re ready.

HOLY 💩, HERE IT IS. The six peptides PCAC recommended are on the interim enforcement discretion policy, to be published Oct 30! hhs.gov/sites/default/files/… Peptides are BACK like they never shoulda left!

$HIMS 🚨 BREAKING: FDA PEPTIDE POLICY PASSES WHITE HOUSE REVIEW NOW MARKED "CONSISTENT WITH CHANGE" ON REGINFO DATABASE - Review officially concluded Oct. 27 - FDA can now move toward issuing its interim peptide compounding policy - Likely to expand access to certain peptides (eg, BPC-157, TB-500) under regulatory safeguards - Awaiting official FDA publication, could happen any time

A lot of these compound pharmacies are certified scammers Before this space can take the next step, we have to clean up the field Still early

Waymo just got mogged by Tesla in Houston 😳

Truly insane results keep coming in from oral liposomal T. 👀 Patient yesterday ➡️ total T: 2,000+ with NORMAL E2 and hematocrit. Only taking 10 mg BID. No changes in BP or lipids. This is straight up not possible with any other form of testosterone. 🤯 More data needed…

GHK-Cu LPT® has arrived. A compounded 2 mg chewable, bisected copper peptide tablet on Strive’s LPT® liposomal delivery platform. Prescription only. What the literature says about the molecule: GHK-Cu is an endogenous copper-binding peptide, and levels may decline with age. Published peer-reviewed papers on GHK-Cu as an active pharmaceutical ingredient describe potential support for collagen syntheses, skin health and elasticity, tissue integrity, and hair follicle support. What it doesn’t say: anything about this formulation. No clinical studies have been performed on GHK-Cu in LPT® form specifically. The above describes the API as reported in the literature. It isn’t efficacy or safety data for this compounded product, and frankly, we won’t present it as such. Literature is a starting point. What belongs in a patient's plan is a provider's call. Not for everyone. Not for use by people with active cancers, or by pregnant or breastfeeding individuals. Not for use in individuals with known allergies to copper compounded or peptides, or with copper metabolism disorders like Wilson’s disease. Always use under medical supervision; monitor for possible unwanted side effects and discontinue if serious symptoms occur. Prescribers: no prior authorization required. Send a patient-specific prescription. Your Strive rep has formulation details and dosing references. Compounded medications are specially prepared for identified individual patient needs based on a valid prescription from a prescribing healthcare practitioner and, as such, are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. Compounded drugs are intended for patients whose prescriber has determined their medical needs are not met by an available FDA-approved drug. These statements have not been evaluated by the FDA. LPT® is a United States registered trademark licensed by Strive Pharmacy.